AP NEWS
Press release content from Business Wire. The AP news staff was not involved in its creation.
PRESS RELEASE: Paid content from Business Wire
Press release content from Business Wire. The AP news staff was not involved in its creation.

Children’s Hospital Los Angeles Receives $1.6M Grant to Study Retinoblastoma

March 18, 2019
A cancer gene called MYCN (red) appears in high levels in cone cells (green). These cone cells can go on to form retinoblastoma tumors. Image provided by Dr. Hardeep Singh, Children's Hospital Los Angeles.

LOS ANGELES--(BUSINESS WIRE)--Mar 18, 2019--Retinoblastoma is a tumor of the retina that generally affects children under 5 years of age and accounts for approximately 4% of childhood cancers. If not diagnosed early, retinoblastoma may result in loss of one or both eyes and can be fatal. David Cobrinik, MD, PhD, of The Saban Research Institute and The Vision Center at Children’s Hospital Los Angeles, has made key discoveries to advance our understanding of this cancer. His team showed that retinoblastoma arises from abnormal proliferation of a cell type called cones in the retina, the light-sensing layer behind the eye. A mutation in a tumor-suppressing gene called RB effectively releases a brake on cell growth, causing cones to grow out of control and form a tumor. Children who inherit a mutated form of RB have more than a 95% chance of getting retinoblastoma. Given this strong correlation, an understanding of how RB mutations affect cone cells could lead scientists towards an intervention in the disease.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190318005836/en/

A cancer gene called MYCN (red) appears in high levels in cone cells (green). These cone cells can go on to form retinoblastoma tumors. Image provided by Dr. Hardeep Singh, Children’s Hospital Los Angeles.

Dr. Cobrinik received a $1.6M grant from the National Cancer Institute of the NIH to study what causes cone cells to proliferate and form tumors. Though the genetic mutation is identified, we still must understand how RB mutation affects cone cells. What makes a cell turn cancerous? Why are cone cells vulnerable to this mutation? To answer these questions, Dr. Cobrinik explains, we must understand the normal function of RB and what it is doing to block tumor formation in healthy individuals. “If we can understand this,” Dr. Cobrinik says, “we might have the opportunity to prevent the tumor process.” While his research is focused on retinoblastoma, understanding how tumor-suppressing genes affect healthy cells could open up avenues for treatment in many cancer types.

About Children’s Hospital Los Angeles

Children’s Hospital Los Angeles has been ranked the top children’s hospital in California and sixth in the nation for clinical excellence by the prestigious U.S. News & World Report Honor Roll. The Saban Research Institute at CHLA is one of the largest and most productive pediatric research facilities in the United States. CHLA also is one of America’s premier teaching hospitals through its affiliation since 1932 with the Keck School of Medicine of the University of Southern California. For more, visit CHLA.org, the child health blog and the research blog.

View source version on businesswire.com:https://www.businesswire.com/news/home/20190318005836/en/

CONTACT: Media ContactEllin Kavanagh

ekavanagh@chla.usc.edu

(323) 361-8505

KEYWORD: UNITED STATES NORTH AMERICA CALIFORNIA

INDUSTRY KEYWORD: HEALTH BIOTECHNOLOGY HOSPITALS ONCOLOGY OPTICAL RESEARCH SCIENCE

SOURCE: Children’s Hospital Los Angeles

Copyright Business Wire 2019.

PUB: 03/18/2019 06:39 PM/DISC: 03/18/2019 06:39 PM

http://www.businesswire.com/news/home/20190318005836/en